Tag Archive: surgery


Today’s case is not in the ED.  This one unfolds on the ward – the morning after the admission.  So imagine yourself there – on the Paeds surgical ward.

6 year old boy was admitted last evening after referral from the local GP to the on-call Surg team.

He has a 24 hour history of increasing central abdominal pain.  The pain wa initially periumbilical, but overnight it has localized to the lower abdomen – maybe a bit more on the right. Urinalysis was normal

The surgical team have been on their super-early orning rounds and seen the child – they have written in the notes:

tender lower abdo, no rebound, guarding, otherwise soft, afebrile.  Bloods all normal.  PLAN:  Med team consult please.? epurients

OK, now that is Surg -speak for – we aren’t operating on this kid – not a likely appendix.  Turf to med, maybe its constipation?

Half way though your ward round the nurse- coordinator calls you to say:  “You had better come see this kid – he has just had a bout of melena

Hmmmm… not sounding like your average “un-appendix”.  So you pop in and see him.  Mum is looking worried.  His obs are normal, his belly is ‘as described’ by the Surg team.  When you pull down his jocks for a gander at his bottom you notice his scrotum is a bit red, and on examination his left testis is tender and there is a definite hydrocoele.  Hmmmmm…

OK – can you solve this Paediatric puzzle?

What is going on?  Well here is the clincher.

Rash

What are you going to do next?

Congrats to Dr Bek – who as it turns out practices about 500m down the road from me at the local Aboriginal Medical Service.  Bek gave the right and most insightful answer.  Good call from Maj and Patrick also – honorable commendations.  I happen to know Bek was at a recent talk I gave which covered HSP – so technically she did cheat? But I think she already knew before I got to her!

HSP (Henoch-Shonlein purpura) is an IgA-mediated leukocyoclastic vasculitis which produces a syndrome in children as described by the eponymous gents (and Heberden 30 years earlier). They described the quadrad of: purpura, arthralgia, abdominal pain and melena. Of course, they missed the meat – the renal disease. The disease involves a vasculitis of small vessels in the skin, gut, joints, glomeruli etc. It is pretty much the same disease as IgA nephropahy (Berger’s disease) in adults. HSP ends to occur in young children 4 – 10

I love HSP as a diagnosis as it is one of those end-of-the-bed diagnoses which can present in a number of ways – a rash, joint pain, belly aches etc. You have to keep it in you thoughts or you might miss it. The diagnosis is basically clinical – unless it is unclear as to the cause of the rash – so you might check for other causes of purpura. As opposed to ITP etc the platelets will be normal or elevated.

Treatment is mainly symptomatic – analgesia and “surgical” management of complications such as intussusception or torsion. GI bleeding, abdo pain and joint pain are usually treated with oral steroids. Does it work?  Well – maybe.  There are papers in both direction but they are all small and lack the power to say yes or no.  A rough summary is that they might make you belly pain get better sooner,  make the likelihood of an operation or CT scan lower and just might improve joint symptoms.  Now onto the million dollar question… the beans.

The reason HSP is an important problem in the long term is that there is an incidence of chronic renal disease. Usually a nephritic syndrome (though some mixed or nephrotic). And some of these kids will progress to renal failure. Here is the problem – there are studies that show that early steroids, and even cyclophosphamide do not reduce this progression. So we cannot treat the serious complication.

Monitoring includes urinalysis testing, BP monitoring – as there is about a 7% recurrence rate and the risk of renal disease goes up with recurrence and older-age of the kid.

 

Hope you guys enjoyed the case. Here is the discussion and hopefully some useful take home concepts.

This case illustrated a number of key acute and chronic pain concepts that all GP anaesthetists should consider when anaesthetising an opioid tolerant chronic pain patient, namely opioid induced hyperalgesia (OIH), central sensitization (wind up) and pre-emptive analgesia.

In this case, our patient did not receive adequate perioperative analgesia or pre-emptive analgesia based on his chronic pain and opioid dependent background. He was left in distress for a period of time in which his pain became unmanageable (wind up) and remained so for 16 hours. It seemingly became non-responsive (OIH) to opioids but rotation to a new opioid, a background infusion of a NMDA antagonist and the use of a regional technique helped immensely.

Opioid induced Hyperalgesia

Opioid induced hyperalgesia is a paradoxical response to opioids in which patient receiving opioids have an enhanced response to painful stimuli resulting in hyperalgesia. This results from the upregulation of pronociceptive pathways in the central and peripheral nervous system.

Acute OIH occurs in various settings, most commonly post operatively in the opioid dependent patient but also in low dose and maintenance dose regimes. OIH is distinct from tolerance in that tolerance is reduced effectiveness of an opioid at a receptor over time.

NMDA receptor activation is important in the development of OIH. Antagonism of this receptor has been shown to reduce progression and improve post operative pain especially in opioid dependent patients (Wu + Macintyre + Huxtable et al).

Using an opioid PCA in opioid tolerant patients allows consumption and background requirements to be monitored. A basal infusion equivalent to the patient’s usual daily opioid use should be considered or given orally as tolerated.

Ketamine has been shown to reduce OIH in the post-operative setting (Vadivelu + Huxtable + Macintyre et al). There is evidence that subanaesthetic doses (0.1-0.2mg/kg) of ketamine provides excellent analgesia in opioid dependent patients and prevents opioid induced hyperalgesia in patients consuming high doses of opioid for postoperative relief. (Macintyre et al + Vadivelu et al).

Opioid rotation is the practice switching from one opioid to another to improve analgesia and reduce side effects (OIH in this case). This concept is based on the premise that individual opioids act differently on different opioid receptors and that tolerance between them is likely to be incomplete.

Practically this is preformed by using opioid equivalence charts and commencing with 50% of the equivalent dose and titrating up. (Huxtable)

Methadone together with its mu-receptor agonism has weak antagonistic properties on the NMDA receptor thereby playing a small role in OIH.

Wind up (central sensitization)

Post-operative pain results from peripheral nociception (primary hyperalgesia) from tissue injury and resultant central nociception (secondary hyperalgesia) in the spinal cord.

Any continuous barrage of activity to the spinal chord leads to central sensitization. Perioperatively this is related to periods of inadequate analgesia, extensive surgery or infection (Shipton).

As this central sensitization continues from the noxious stimuli, this maintains secondary hyperalgesia, amplifies post operative pain and contributes to chronic pain.  Central sensitization will manifest clinically as hyperalgesia (increased pain sensitivity) and allodynia (pain in response to a previously non-painful stimulus) (Macintyre et al).

 

NMDA receptor activation plays a key role in central sensitization. Medications such as Gabapentin, Pregabalin and Ketamine have been found to improve post operative pain and thought to reduce the progression to chronic pain.

Using Ketamine at subanaesthetic doses (0.1-0.2mg/kg) antagonizes the NMDA receptor and produces an antihyperalgesic, antiallodynic and anti-tolerance effect. It is useful in pain associated with central sensitization such as severe acute pain and opioid resistant pain.

Pregabalin is a safe and well tolerated and helps to reduce perioperative opioid consumption. It has been shown to decrease the incidence in the progression to chronic pain. Gabapentin similarly has been shown to prevent chronic post surgical pain syndromes (Shipton).

Pre-emptive & Preventative Analgesia

Pre-emptive analgesia is treatment that is initiated before the surgical procedure in order to reduce peripheral and central sensitization. This in effect helps to reduce post operative pain and prevent chronic pain development (Dahl)

Preventive analgesia is simply the well thought out provision of analgesia within the postoperative period and persistence of treatment beyond the expected duration and aims to minimize central sensitisation (Macintyre et al)

Ketamine modulates central sensitization caused by incision and tissue damage and can be used perioperatively to antagonize this (Vadivelu).

Preoperative pregabalin is opioid sparing and improves post operative pain scores. It is a useful adjuvant and anti-hyperalgesic agent used in a multimodal regime.

Prevention of Withdrawal

Inadequate opioid supplementations in the post operative period can lead to withdrawal characterized by excitatory autonomic symptoms. The onset will depend on the individual opioid’s duration of action (Macintyre et al).

Opioid tolerant patients should firstly be identified preoperatively and continue their preadmission opioid regimes with appropriate route substitutions as clinically directed.

Heavily weighted non-opioid regimes should be used with caution as opioid tolerant patient due their risk of withdrawal (e.g.: pure non opioid regime or tramadol as a sole opioid).

If withdrawal is suspected, Clondine can be used orally and intravenously to aid in the symptomatic management.

 

Key Messages

Preoperatively identify opioid tolerant and chronic pain patients and make a peri/post operative analgesia plan

 Always replace a patient’s preoperative opioid use in the post-surgical period

Consider preventative analgesics such as Ketamine, Pregabalin and Gabapentin to prevent central sensitization and subsequently wind up pain.

Consider an opioid rotation in patients who respond poorly to an opioid regime or with escalating requirements

Reverse analgesic ladder on recovery with background opiate titration

 

Hope this helps. Let me know what you think.

Jonathan

 

Baron R (2006) Mechanisms of Disease: neuropathic pain – a clinical perspective. Nature Clinical Practice Neurology 2: 95-106 http://www.nature.com/nrneurol/journal/v2/n2/full/ncpneuro0113.html

Dahl JB, Moinche S (2004) Pre-emptive analgesia. British Medical Bulletin 71(1) 13-27 http://bmb.oxfordjournals.org/content/71/1/13.long

Huxtable CA et al (2011) Acute pain management in opioid-tolerant patients: a growing challenge. Anaesthesia & Intensive Care 39: 804-823 http://www.aaic.net.au/document/?D=20110262

Macintyre PE et al (2010) Acute Pain Management: Scientific Evidence 3rd Edition. Australian & New Zealand College of Anaesthetists & Faculty of Pain Medicine http://www.anzca.edu.au/resources/college-publications/Acute%20Pain%20Management/books-and-publications/acutepain.pdf

Mitra S et al (2004) Perioperative Management of Acute in the Opioid dependent Patient. Anesthesiology 101: 212-27 http://journals.lww.com/anesthesiology/Fulltext/2004/07000/Perioperative_Management_of_Acute_Pain_in_the.32.aspx

Patanwala A et al (2007) Opioid Conversion in Acute Care. Annals of Pharmacotherapy 41: 255-67 http://www.theannals.com/content/41/2/255

Shipton E.A (2011) The transition from acute to chronic post surgical pain. Anaesthesia & Intensive Care 39: 824-836 http://www.aaic.net.au/document/?D=20110056

Vadivelu N et al (2010) Recent Advances in Postoperative Pain Management. Yale Journal of Biology and Medicine 83: 11-25 http://www.ncbi.nlm.nih.gov/pubmed/20351978

Wu CL et al (2011) Treatment of acute postoperative pain. Lancet 377: 2215-25 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60245-6/abstract

Broome is possibly one of the pus capitals of the world.  We have pus in all shades, colours and odours.  High rates of Staph. and strept disease combined with a humid, hot environment where nobody ever wears shoes (no matter how bad their diabetes) means that we see a lot of skin infections.

Most of us think we are good at picking the cellulitis from and abscess – or on a more practical level – whom we attack with a scalpel and who we just poison with antibiotics!  But are we really good at it – clinically picking cellulitis from a drainable collection?

The boys from Emergency Ultrasound Podcast recently did a podcast on quinsy – and buried in there was a reference to a nice observational study that looked at ED docs, their guess as to wether the cellulitis was really an abscess, then an US in the ED, and numbers on how often they changed their management asa result.   The study was by Tayal et al, in Acad. Emergency Med 2008.  Basically it showed that they were wrong a lot:  about half of the “cellulitis” patients had a drainable collection on US – and management was surgical.  And nearly 3/4 of the ones they thought were abscesses were managed by either antibiotics or ‘further investigation’ – that is: they ended up cutting a lot less people unecessarily.

For me this confirmed my suspicions – my in-my-mind-casey-series, I have found that I cut a lot less since I started running the probe over the area and looking beneath the skin.  It takes about a minute to do, and saves a lot of time and pain in the ED.

So – I scan more and cut less – everybody wins!

Now, if you do find an abscess and decide to drain it – how should you do it and should you pack it with gauze etc?

I found these gems of knowledge as I was researching this topic and thought I should share.  Packing the abscess cavity has always been taught as a way to keep the cavity open to allow drainage and prevent recurrence / recollection of the pus.  Sounds goo in theory – but it might just be one of those medical memes that don’t really stand up to the light of closer study.  Ashley Shreeves from the NNT did a review on this and found a few studies that compared packing vs. no-packing techniques  and ‘open’  vs ‘Closed’ surgical approaches.  Basically the techniques resulted in no difference in outcomes and the packing was significantly more painful than not packing – so from a patient’s POV it would seem an unnecessary thing to do!

So, now you are probably asking: what is a closed technique?  Well it seems that a closed approach involves doing an incision, drainage and then suturing the wound closed – this was surgical heresy where I trained.  We were told to never closed a pus cavity -it must be left open to let out the bad juju.  Last year this review in the American Journ Of Emerg Med by Singer et al showed that this was not true.  Healing was significantly faster in the closed group than the open group, and there was no significant difference in recurrence rates.  So maybe we should sew these up?  Love to hear your current practice and how this data effects it…

Finally I would like to recommend this offering from Rob Orman of ERCast fame.  Rob delivers a punchy video describing his “loop abscess drainage” technique.  I guess this is the same deal as draining and then closing if done well.  I think it is an approach I might try for a while and see how the patients like it – it might be a winner – and for me the most important thing is a happy patient with a small scar and less pain.

Let me know if you have a technique that achieves all this.

Casey

Hi – Apologies for recent sluggish activity- I have been a busy Doc lately and working on what I hope are some good posts / resources for you all.

The first Big project I am wanting your feedback on is my “Massive Transfusion Protocol” which you can click here – or I have added as a permanent resource in the “Clinical Resources” section at the bottom of the blog.

Why have I decided to spend hours on this? 

I have always found the current published Massive Bleeding Protocols to be either too simplistic or not descriptive enough.  There are a few crucial decision points – such as” when to activate” – which are glossed over frequently.

Most protocols deal only with trauma – and in my world, the big bleeding happens on the labour ward, in theatre… etc NOT just in the ED resus bay.

So I have written a protocol for me – one which I can with a click on a page access and remind myself of the steps and “recipes” for resuscitaing in major trauma / bleeding.  I have downgraded the role of platelets – because – we do not use them in smaller hospitals and the evidence is not great for empirical use.

I have tried to include some evidence in a ‘hidden’ way to keep it simple in a crisis – or you can read at your leisure later.

Be aware: this protocol relies heavily on your hospital having in place a system-wide approach to this emergency. Your lab have to have a predefined system, your surgeon should be aware of the protocol and the concepts associated with “damage control” operations. This is not the time to get into a territorial dispute, you need to have your chickens all lined up before it happens!

So please read it- this is my draft, I hope to make it more useful with your feedback.

Let me know what you think.  Casey

OK after Clinical Case 031 I was inspired to go out and slog through the literature and try to discover what is “best practice” for traumatic bleeding, then try and work out what is important, what we can do in small or remote hospitals and what is just too expensive / difficult / marginal or plain impossible to do in the bush.  There was a great review in Critical Care last year by Rossaint et al – Updated European Guidelines - so I have used this as a starting point.  Also a review by Curry et al looked at similar data / trials.

So I spent time going over the evidence, and came up with the post below.  The evidence is there, so you can read it for yourself, however, there is no evidence for my opinions – that you can decide for yourself.  As always – I have tried to keep it simple, my brain being the filter for your reading pleasure!  I have given each “recommendation” a grade from A to F (A = gotta do it,\; C = maybe useful; and F = ‘don’t go there’…)  So here it is….it is big, apologies!

This is an A1 recommendation. In patients who are either unstable or have an identified source of bleeding – they need an operation as soon as possible. Time is vital to outcomes.  Let me repeat – if you know where the blood is leaking from – plug it ASAP – do not resuscitate in lieu of intervening with a procedure.

So for the small centres – this means getting into an OT as soon as you can, less time in ED and less fiddling with resuscitation efforts prior to surgery. If you work in a town without a surgeon – then mobilising retrieval early is important. I have on a few occasions arranged for a surgeon to be flown in with the crew to operate prior to transfer.

If your patient responds well to initial resuscitation measures – then you have time, but it should be clear that they need to get to a place where they can get an urgent operation ASAP

We have all been through ATLS or EMST and learned about primary and secondary surveys. What I will say is that there is not much evidence to suport this strategy, but it is universal and you have to do it. However, doing the classic ABCs doesn’t really help you when it comes to the reality of big bleeding patients – the evidence has moved on a bit.

Your initial clinical assessment should answer the following questions:

  1.  mechanism: is this a significant injury? eg. energy of blunt impact, penetrating abdo or thoracic trauma, head injury with any change in GCS.
  2. Pattern of injury:  is this a cluster of injuries, rather than a single overt lesion.  Along with mechanism, the presence of a cluster of injuries should get you worried.
  3. Patient’s physiology / obs / general presentation:  the obs are helpful, but can be normal despite significant bleeds, especially in fit, young people.  You can use the ATLS guide to shock, but know it can be wrong
  4. Response to initial resuscitation – for me this is more useful than the absolute numbers.  The ATLS folks divide these into: rapid responders, transient responders and minimal / non-responders.  You get the idea – give a bit of fluid and watch closely – are you winning?  A pragmatist’s approach to shock – I love this concept – use it every day in my practice.

If you have a patient presenting in shock after trauma and it is unclear as to where the bleeding is coming from then you have to find it fast. If you find it – then you are in the position to intervene.

Resuscitation without identifying the source can waste valuable time. In reality the resus and investigation happen in parallel ideally.

So what investigations? they are guided by you initial assessment, but empirical CXR, pelvis and FAST scanning are mandatory.  The evidence discusses DPL (diagnostic peritoneal lavage) but in my world this is not done – maybe if you have a surgeon with experience, but a FAST is hard to beat when you look at the numbers.  Image anything else you find on you secondary survey.

Shock is defined as tissue hypoperfusion, and this does not equate to the blood pressure. [There is a whole other post coming up on this concept!]

So what measures tissue hypoperfusion? at this stage, serum lactate is your most evidence-based test.  Base deficit is also used with less evidence to support it – but in my hospital they both spit out on the same gas analysis – so use both.  Beware the youngish, sweating / spewing chap with a normalish BP and high lactate – he is on his way to crashville.  [See this article on 'Cryptic sepsis']

I was taught to aim for a low normal ET CO2, but the evidence now suggests this is wrong. The Guidelines recommend normocapnea.

Hyperventilation is associated with poor outcomes (even in brain-injury) including increased mortality, decreased cardiac output and all round badness.

The vent strategy is essentially the same strategy the ARDS Net folks came up with for lung injured patients. The recipe is – low tidal volume (eg. 6 ml/kg IBW), higher RR to keep the minute volume up and clear CO2, and add PEEP to maintain open airways and titrate to oxygenation.  See my case on postop PEEP++ for an example of this strategy.  I now use this on all my intubated patients (even elective gallbags) -unless they have COPD / bad asthma / obstruction.

The evidence shows that using Hct alone is about as good as tossing a coin in the air! It is a poor predictor of volume lost or prognosis. I think you can put Hb in the same basket. It is good to know and use serial assessments, but it is just a part of your more global assessment.

Not a lot of evidence. But it makes sense to try and detect coagulopathy early by testing for it. Of course clinical observation of bleeding and knowing how much fluid / blood has been given can allow you to anticipate ACoTS before the lab can tell you the numbers are bad. The studies did not show much benefit but we should probably check the INR, APTT, platelets and fibrinogen levels. In my practice – I start giving FFP, etc before the labs go bad in the big bleeders – I think this is because – (1) it makes sense to get ahead of the game and (2) the lab can be slow, over an hour to get some results – too late usually.  So if your lab wants confirmation of coagulopathy before the take the FFP out of the freezer – you need to have a ‘meeting’ and change this!

The future includes thromboelastography – this is basically a test of clot strength.  This is used to guide treatment with a variety of coagulation factors – but don’t hold your breath in the regional hospitals – this is still a long way off!

There are some bleeds that need something simple done.

(1) arterial bleeding from and extremity. There is a growing body of evidence from the military showing the safety and improved mortality of torniquet use. See my previous post on Life AND Limb

(2)  Pelvic fracture stabilisation. This depends on where you are and what you have got – but a bed sheet tied around the trochanters is infinitely better than nothin’.  If you have a purpose designed pelvis binder-  then better.  For most small hospitals, that is as good as it gets.  The goal is to make the pelvic volume as small as possible by reducing the injury.

Embolisation seems to be the done thing if you have an angio suite at your disposal.

If you have not heard of this concept before – it basically consists of 3 stages:

(1) Brief ‘resuscitative laparotomy’ – control active bleeding, remove contamination, pack the abdomen and get out

(2) Off to ICU for resuscitation and normalisation of the acidosis, hypothermia and coagulopathy. Optimise fluid status and ventilatory management.

(3) Return to OT for a definitive fix of the injuries / closure of wounds.  This may be hours to days later depending on the injury

There are no RCTs to support this but a lot of retrospective data supports it – it is the new standard of care for the severe end of the trauma spectrum – especially those who have significant acidosis, coagulopathy and low core temp at the outset.

Here we run into some controversy / uncertainty in the literature. What fluid, how much, targets of resus?

Which fluid?  Crystalloids remain the first line.  Most trauma patients now get them en route to the ED.  However, there is evidence showing a direct survival relationship between the volume of crystalloid and mortality.  So if you use them I think it is as a bridge to getting some blood ready.  In my experience too many crystalloids are given in an attempt to get the BP up to unnecessary heights (We are treating our own pulse, rather than the patient’s!)

Which crystalloid – well CSL, Ringer’s etc are good if you patient is acidotic.  See Emcrit’s Acid-base lectures on this.  Saline seems popular – but why? I don’t know, tradition?  It doesn’t make sense in terms of acidosis management – makes it worse not better!

Hypertonic saline (7.5% + dextran) is the new concept here – smaller volumes, and has been used extensively on the Mid-East battlefields.  Watch this space…

Blood products – packed red cells, FFP in my hospital  - these are the mainstay of volume resuscitation in severe trauma.  How to use them – well the Guidelines suggest a target of Hb = 70 – 90 g/L.  However if you are doing a “sympatholytic” resuscitation or “controlled volume / permissive hypotension” then you titrate the fluids to the BP – aiming for a MAP above 65.  Yes, I said 65, which is same as 75/60, or about 80 systolic for round numbers.  This seems low to those of us who trained in Anaesthesia, but that is what the evidence says!

How much?  Well – enough, and just that much – until you can get control of the bleeding source(s).  As above target is MAP > 65.  If you can measure other markers of preload eg. IVC collapse or SVV maybe you can titrate to those as well?  Not sure of the evidence here…

An important caveat to this:  if you have a head-injured or spinal cord patient – then you need a higher target SBP – you probably want to aim for triple figures here [100+]

Ratio of RBCs to FFP (+/- platelets)?  This is a tricky question.  The evidence for RBCs and FFP is much better than adding platelets into the mix, fortunately most small hospitals don’t keep platelets – so the decision to not use them is very easy!  Lots of retrospective, registry analysis of the RBC:FFP ratios has been done.   1:1 is popular, however the dust seems to settle with a ratio somewhere between 1:2 and 1:3 giving the best outcomes.  In the reality of rural practice you have already given at least 4 bags of red before the first FFP is thawed, so I aim for a 1:1 after the FFP is available – the ratio then eventually approaches 1:1 as you give more and more volume, and if you stop early then they probably were not as sick as you thought?  No evidence, just bloody-minded pragmatism.

Calcium has many jobs to do, and in bleeding it has a crucial role in: inotropy, coagulation factors and avoiding citrate toxicity in massive transfusion.

Calcium can be given as CaCl, or Ca-gluconate.  Basically the Ca++ in CaCl is immediately available, but harsh on the veins.  Ca-gluc is cleaved by the liver to release into the plasma ionised Ca++. In severe shock you might want to go with CaCL as hepatic metabolism might be impaired.

The goal is to get the ionised Ca++ level up to around 1.0 mmol/l, acidosis does reduce the available Ca+.

The evidence for the infusion of platelets is not as good as FFP. There are studies showing improved survival if the ratios infused were better than 1:5. In most small hospitals it is a non-argument – they are just too hard to store and not gonna get used frequently enough to justify the expense. If you are giving platelets the recommendation is to aim for a level of 50, or maybe 100 for the brain-injured.

These contain a variety of clotting factors – but importantly they are the only real source of fibrinogen in modern practice. (although FFP has fibrinogen also). This should be used if you show a low fibrinogen level.  This might be viable in small places – though does it add more than just giving more FFP?

PCC is a combo of the vit K dependent factors, protein C and S. It is stored for a good period and doesn’t need cross matching – so it is easy to use. It is expensive, but the in vivo testing(in animal models) shows it is effective for reversing coagulopathy of trauma – better than FFP in ‘mildly hypothermic pigs’.  Not just for those on warfarin. There is a theoretical risk of thrombotic events – so use some mechanical prophylaxis to prevent DVT.  There are a few small trials and reviews: Critical care, and Euro Journ Anaesthesiology.

I think this is viable in the smaller hospitals – easy to store, use and has effects.  I think I might pester the accounting department about this….

This is really controversial. rFVII is super- expensive and hasn’ really passed the evidence-in-practice test from what I can see. It seems to be down the bottom of all the algorithms, and hear this – you need to have all your ducks in a row before using it – make sure the other factors are all replenished, the big vessels are tied and your Ca, fibrinogen and pH are all sweet. For me this is likely not enough bang for my buck in a small centre.

This is not a drug for trauma. Full stop. If you have a bleeder with known vWF problem then you might talk to a Haematologist about it.

CRASH-2 was a huge trial that looked at IV tranexamic acid for trauma. And it showed a mortality benefit – only a small one though – ~ 1.5%.  It was safe though – so not much downside.  Did not reduce the volume of blood required – so may not help you in the instant…

Caveats – you have to use it early.  Get the initial bolus in ASAP then you have a slow 8 hour bag to run in at your leisure.  For me this is now something I do in my hospital – it is cheap and pretty easy.

Watch out for upcoming trials in obstetric bleeding – might be another string to our bow there too!

Sorry folks – it was a marathon of mostly my ramblings and I am asking you to take my word on all of that – but the evidence is not very clear in this field – there are many ways to “resuscitate an exsanguinating cat”.  I would love to hear your questions and comments – so I know if this is total gibberish or if you think it might apply to your place.  Hit me on the comments.

Casey